Charles J. Paget
Charles J. Paget publishes mostly in Organic Chemistry, Surgery and Oncology, on topics such as Synthesis and biological activity, Synthesis and Characterization of Heterocyclic Compounds and Synthesis and Biological Evaluation.
- World rank
- #3,277,550 of 7,710,434 ranked researchers
- Rank in United States
- #927,552 of 1,627,098
- Works
- 35
- Citations
- 512
- Citations per work
- 14.6
What does Charles J. Paget research?
Charles J. Paget's work is mostly in Chemistry (38%), Medicine (24%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences1337.6%
- Chemistry1337.6%
- Everything else1233.4%
- Health Sciences823.6%
- Medicine823.6%
- Life Sciences25.4%
- 1Organic Chemistry38% of their works
- 2Surgery9% of their works
- 3Oncology9% of their works
- 4Molecular Biology5% of their works
- 5Pharmacology3% of their works
- 6Pulmonary and Respiratory Medicine3% of their works
Research topics
- Synthesis and biological activity
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Structural and Chemical Analysis of Organic and Inorganic Compounds
- Synthesis and Reactivity of Sulfur-Containing Compounds
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Reactions of Organic Compounds
- Surgical Simulation and Training
Which keywords describe Charles J. Paget's research?
The keywords of their largest research topics: Synthesis, Heterocycles, Antimicrobial, Biological Evaluation, Heterocyclic Compounds, Medicinal Chemistry, Microwave-Assisted Synthesis and Anticancer.
- Virtual Reality Training
- Phenothiazines
- Imidazoles
- Thionation
- Thiadiazoles
- Oxadiazoles
- Vascular Targeting Agents
- Triazines
- Chemoselective
- Anticancer
- Medicinal Chemistry
- Biological Evaluation
- Heterocycles
- Synthesis
- Antimicrobial
- Heterocyclic Compounds
- Microwave-Assisted Synthesis
- Catalyst
- Drug Discovery
- Tubulin Inhibitors
- Antimicrobial Activity
- Quinoxaline
- Thioamides
- Biological Activities
- Oxazolones
- Surgical Skills
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 26 words, with their numbers
- Synthesis225 topics
- Heterocycles184 topics
- Antimicrobial143 topics
- Biological Evaluation112 topics
- Heterocyclic Compounds112 topics
- Medicinal Chemistry112 topics
- Microwave-Assisted Synthesis102 topics
- Anticancer92 topics
- Catalyst82 topics
- Chemoselective72 topics
- Drug Discovery61 topic
- Triazines61 topic
- Tubulin Inhibitors61 topic
- Vascular Targeting Agents61 topic
- Antimicrobial Activity51 topic
- Oxadiazoles51 topic
- Quinoxaline51 topic
- Thiadiazoles51 topic
- Thioamides41 topic
- Thionation41 topic
- Biological Activities31 topic
- Imidazoles31 topic
- Oxazolones31 topic
- Phenothiazines31 topic
- Surgical Skills31 topic
- Virtual Reality Training31 topic
Where does Charles J. Paget work?
Charles J. Paget's main affiliation in the publication record is Carilion Clinic, United States.
How many publications and citations does Charles J. Paget have?
OpenAlex counts 35 works and 512 citations for Charles J. Paget, an h-index of 10, ranking #3,277,550 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Charles J. Paget. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.